| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 266-IP-010/CF | |||
| Carrier Free | 266-IP-050/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF-466-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB266-SP | |||
| Carrier Free | MAB266-500 | |||
| Carrier Free | IC266V-100UG | |||
| Carrier Free | IC266U-100UG | |||
| Carrier Free | IC266T-100UG | |||
| Carrier Free | IC266S-100UG | |||
| Carrier Free | IC266R-100UG | |||
| Carrier Free | IC266N-100UG | |||
| Carrier Free | IC266G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF-266-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB466-SP | |||
| Carrier Free | MAB466-500 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 466-CR-050/CF | |||
![N/A CXCL10/IP-10/CRG-2 [HRP]](http://images.novusbio.com/fullsize2/DATA_CXCL10_DIP100_ELISA_723.jpg "N/A CXCL10/IP-10/CRG-2 [HRP]")
![N/A CXCL10/IP-10/CRG-2 [HRP]](http://images.novusbio.com/fullsize2/DATA_CXCL10_DIP100_ELISA_724.jpg)
![N/A CXCL10/IP-10/CRG-2 [HRP]](http://images.novusbio.com/fullsize2/CXCL10_DIP100_ELISA_121.jpg)
![N/A CXCL10/IP-10/CRG-2 [Biotin]](http://images.novusbio.com/fullsize2/DATA_CXCL10_DY266_ELISA_1870.jpg "N/A CXCL10/IP-10/CRG-2 [Biotin]")
![N/A CXCL10/IP-10/CRG-2 [Biotin]](http://images.novusbio.com/fullsize2/DATA_CXCL10_DY466_ELISA_2048.jpg "N/A CXCL10/IP-10/CRG-2 [Biotin]")
![Immunocytochemistry/Immunofluorescence: CXCL10/IP-10/CRG-2 Antibody (JA10-82) [NBP2-67004] - Staining IP10 in N2A cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CXCL10-IP-10-CRG-2-Antibody-JA10-82-Immunocytochemistry-Immunofluorescence-NBP2-67004-img0004.jpg "Immunocytochemistry/Immunofluorescence: CXCL10/IP-10/CRG-2 Antibody (JA10-82) [NBP2-67004] - Staining IP10 in N2A cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.")
![Immunohistochemistry-Paraffin: CXCL10/IP-10/CRG-2 Antibody (JA10-82) [NBP2-67004] - Human tonsil tissue using anti-IP10 antibody. The section was pre-treated using heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0) for 20 minutes.The tissues were blocked in 1% BSA for 30 minutes at room temperature, washed with ddH2O and PBS, and then probed with the primary antibody (1/400) for 30 minutes at room temperature. The detection was performed using an HRP conjugated compact polymer system. DAB was used as the chromogen. Tissues were counterstained with hematoxylin and mounted with DPX.](http://images.novusbio.com/fullsize/CXCL10-IP-10-CRG-2-Antibody-JA10-82-Immunohistochemistry-Paraffin-NBP2-67004-img0005.jpg)
![Immunocytochemistry/Immunofluorescence: CXCL10/IP-10/CRG-2 Antibody (JA10-82) [NBP2-67004] - Staining IP10 in HepG2 cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CXCL10-IP-10-CRG-2-Antibody-JA10-82-Immunocytochemistry-Immunofluorescence-NBP2-67004-img0001.jpg)
![Immunocytochemistry/Immunofluorescence: CXCL10/IP-10/CRG-2 Antibody (JA10-82) [NBP2-67004] - Staining IP10 in SH-SY5Y cells (red). The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.](http://images.novusbio.com/fullsize/CXCL10-IP-10-CRG-2-Antibody-JA10-82-Immunocytochemistry-Immunofluorescence-NBP2-67004-img0003.jpg)
![Immunohistochemistry-Paraffin: CXCL10/IP-10/CRG-2 Antibody (JA10-82) [NBP2-67004] - Analysis of paraffin-embedded human skin tissue using anti-IP10 antibody. Counter stained with hematoxylin.](http://images.novusbio.com/fullsize/CXCL10-IP-10-CRG-2-Antibody-JA10-82-Immunohistochemistry-Paraffin-NBP2-67004-img0002.jpg)